SCOPUS 정보 검색 플랫폼

Volumn 112, Issue 9, 2013, Pages 1367-1372

A direct comparison of intravenous enoxaparin with unfractionated heparin in primary percutaneous coronary intervention (from the ATOLL Trial)

(20) Collet, Jean Philippe a,b Huber, Kurt c Cohen, Marc d Zeymer, Uwe e Goldstein, Patrick f Pollack, Charles g Silvain, Johanne a,b Henry, Patrick h Varenne, Olivier i Carrié, Didier j Coste, Pierre k Angioi, Michael l Le Breton, Hervé m Cayla, Guillaume n Elhadad, Simon o Teiger, Emmanuel p Filippi, Emmanuelle q Aout, Mounir h Vicaut, Eric h Montalescot, Gilles a,b

a PITIÉ SALPÊTRIÈRE HOSPITAL (France)

b ACTION Study Group (France)

c WILHELMINEN HOSPITAL (Austria)

d NEWARK BETH ISRAEL MEDICAL CENTER (United States)

e KLINIKUM LUDWIGSHAFEN (Germany)

f LILLE UNIVERSITY HOSPITAL (France)

g PENNSYLVANIA HOSPITAL (United States)

h HÔPITAL LARIBOISIÈRE (France)

i Hôpital de Rangueil ^* (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ENOXAPARIN; HEPARIN;

ACUTE CORONARY SYNDROME; ADULT; AGED; ANTICOAGULATION; ARTICLE; BLEEDING; CARDIOVASCULAR RISK; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVASCULARIZATION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

EID: 84885948120 PISSN: 00029149 EISSN: 18791913 Source Type: Journal
DOI: 10.1016/j.amjcard.2013.07.003 Document Type: Article

Times cited : (52)

References (18)

1
- 80051961584
- Intravenous enoxaparin or unfractionated heparin in primary percutaneous coronary intervention for ST-elevation myocardial infarction
- G. Montalescot, U. Zeymer, J. Silvain, B. Boulanger, M. Cohen, P. Goldstein, P. Ecollan, A. Margenet, K. Huber, C. Pollack, J.F. Bénezet, O. Stibbe, E. Filippi, E. Teiger, G. Cayla, S. Elhadad, S. Adnet, T. Chouihed, S. Gallula, A. Greff, M. Aout, J.P. Collet, and E. Vicaut Intravenous enoxaparin or unfractionated heparin in primary percutaneous coronary intervention for ST-elevation myocardial infarction Lancet 378 2011 693 703
- (2011) Lancet , vol.378 , pp. 693-703
- Montalescot, G.¹ Zeymer, U.² Silvain, J.³ Boulanger, B.⁴ Cohen, M.⁵ Goldstein, P.⁶ Ecollan, P.⁷ Margenet, A.⁸ Huber, K.⁹ Pollack, C.¹⁰ Bénezet, J.F.¹¹ Stibbe, O.¹² Filippi, E.¹³ Teiger, E.¹⁴ Cayla, G.¹⁵ Elhadad, S.¹⁶ Adnet, S.¹⁷ Chouihed, T.¹⁸ Gallula, S.¹⁹ Greff, A.²⁰ more..

2
- 33748431522
- Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention
- G. Montalescot, H.D. White, R. Gallo, M. Cohen, P.G. Steg, P.E. Aylward, C. Bode, M. Chiariello, S.B. King 3rd, R.A. Harrington, W.J. Desmet, C. Macaya, and S.R. Steinhubl Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention N Engl J Med 355 2006 1006 1017
- (2006) N Engl J Med , vol.355 , pp. 1006-1017
- Montalescot, G.¹ White, H.D.² Gallo, R.³ Cohen, M.⁴ Steg, P.G.⁵ Aylward, P.E.⁶ Bode, C.⁷ Chiariello, M.⁸ King III, S.B.⁹ Harrington, R.A.¹⁰ Desmet, W.J.¹¹ Macaya, C.¹² Steinhubl, S.R.¹³

3
- 65549102277
- Impact of anticoagulation regimens on sheath management and bleeding in patients undergoing elective percutaneous coronary intervention in the STEEPLE trial
- R. Gallo, S.R. Steinhubl, H.D. White, and G. Montalescot Impact of anticoagulation regimens on sheath management and bleeding in patients undergoing elective percutaneous coronary intervention in the STEEPLE trial Catheter Cardiovasc Interv 73 2009 319 325
- (2009) Catheter Cardiovasc Interv , vol.73 , pp. 319-325
- Gallo, R.¹ Steinhubl, S.R.² White, H.D.³ Montalescot, G.⁴

4
- 0032870952
- Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) 11B trial
- E.M. Antman, C.H. McCabe, E.P. Gurfinkel, A.G. Turpie, P.J. Bernink, D. Salein, A. Bayes De Luna, K. Fox, J.M. Lablanche, D. Radley, J. Premmereur, and E. Braunwald Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) 11B trial Circulation 100 1999 1593 1601
- (1999) Circulation , vol.100 , pp. 1593-1601
- Antman, E.M.¹ McCabe, C.H.² Gurfinkel, E.P.³ Turpie, A.G.⁴ Bernink, P.J.⁵ Salein, D.⁶ Bayes De Luna, A.⁷ Fox, K.⁸ Lablanche, J.M.⁹ Radley, D.¹⁰ Premmereur, J.¹¹ Braunwald, E.¹²

5
- 3042820414
- Safety and efficacy of enoxaparin vs unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes who receive tirofiban and aspirin: A randomized controlled trial
- A to Z investigators
- M.A. Blazing, J.A. de Lemos, H.D. White, K.A. Fox, F.W. Verheugt, D. Ardissino, P.M. DiBattiste, J. Palmisano, D.W. Bilheimer, S.M. Snapinn, K.E. Ramsey, L.H. Gardner, V. Hasselblad, M.A. Pfeffer, E.F. Lewis, E. Braunwald, R.M. Califf A to Z investigators Safety and efficacy of enoxaparin vs unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes who receive tirofiban and aspirin: a randomized controlled trial JAMA 292 2004 55 64
- (2004) JAMA , vol.292 , pp. 55-64
- Blazing, M.A.¹ De Lemos, J.A.² White, H.D.³ Fox, K.A.⁴ Verheugt, F.W.⁵ Ardissino, D.⁶ Dibattiste, P.M.⁷ Palmisano, J.⁸ Bilheimer, D.W.⁹ Snapinn, S.M.¹⁰ Ramsey, K.E.¹¹ Gardner, L.H.¹² Hasselblad, V.¹³ Pfeffer, M.A.¹⁴ Lewis, E.F.¹⁵ Braunwald, E.¹⁶ Califf, R.M.¹⁷

6
- 8544279582
- A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group
- M. Cohen, C. Demers, E.P. Gurfinkel, A.G. Turpie, G.J. Fromell, S. Goodman, A. Langer, R.M. Califf, K.A. Fox, J. Premmereur, and F. Bigonzi A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group N Engl J Med 337 1997 447 452
- (1997) N Engl J Med , vol.337 , pp. 447-452
- Cohen, M.¹ Demers, C.² Gurfinkel, E.P.³ Turpie, A.G.⁴ Fromell, G.J.⁵ Goodman, S.⁶ Langer, A.⁷ Califf, R.M.⁸ Fox, K.A.⁹ Premmereur, J.¹⁰ Bigonzi, F.¹¹

7
- 33748950070
- A subgroup analysis of the impact of prerandomization antithrombin therapy on outcomes in the SYNERGY trial: Enoxaparin versus unfractionated heparin in non-ST-segment elevation acute coronary syndromes
- M. Cohen, K.W. Mahaffey, K. Pieper, C.V. Pollack Jr., E.M. Antman, J. Hoekstra, S.G. Goodman, A. Langer, J.J. Col, H.D. White, R.M. Califf, and J.J. Ferguson A subgroup analysis of the impact of prerandomization antithrombin therapy on outcomes in the SYNERGY trial: enoxaparin versus unfractionated heparin in non-ST-segment elevation acute coronary syndromes J Am Coll Cardiol 48 2006 1346 1354
- (2006) J Am Coll Cardiol , vol.48 , pp. 1346-1354
- Cohen, M.¹ Mahaffey, K.W.² Pieper, K.³ Pollack, Jr.C.V.⁴ Antman, E.M.⁵ Hoekstra, J.⁶ Goodman, S.G.⁷ Langer, A.⁸ Col, J.J.⁹ White, H.D.¹⁰ Califf, R.M.¹¹ Ferguson, J.J.¹²

8
- 0037458122
- Randomized evaluation of the safety and efficacy of enoxaparin versus unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes receiving the glycoprotein IIb/IIIa inhibitor eptifibatide
- S.G. Goodman, D. Fitchett, P.W. Armstrong, M. Tan, and A. Langer Randomized evaluation of the safety and efficacy of enoxaparin versus unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes receiving the glycoprotein IIb/IIIa inhibitor eptifibatide Circulation 107 2003 238 244
- (2003) Circulation , vol.107 , pp. 238-244
- Goodman, S.G.¹ Fitchett, D.² Armstrong, P.W.³ Tan, M.⁴ Langer, A.⁵

9
- 33645497961
- Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction: The OASIS-6 randomized trial
- S. Yusuf, S.R. Mehta, S. Chrolavicius, R. Afzal, J. Pogue, C.B. Granger, A. Budaj, R.J.G. Peters, J.-P. Bassand, L. Wallentin, C. Joyner, and K.A.A. Fox Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction: the OASIS-6 randomized trial JAMA 295 2006 1519 1530
- (2006) JAMA , vol.295 , pp. 1519-1530
- Yusuf, S.¹ Mehta, S.R.² Chrolavicius, S.³ Afzal, R.⁴ Pogue, J.⁵ Granger, C.B.⁶ Budaj, A.⁷ Peters, R.J.G.⁸ Bassand, J.-P.⁹ Wallentin, L.¹⁰ Joyner, C.¹¹ Fox, K.A.A.¹²

10
- 33645498094
- Comparison of fondaparinux and enoxaparin in acute coronary syndromes
- S. Yusuf, S.R. Mehta, S. Chrolavicius, R. Afzal, J. Pogue, C.B. Granger, A. Budaj, R.J.G. Peters, J.-P. Bassand, L. Wallentin, C. Joyner, and K.A.A. Fox Comparison of fondaparinux and enoxaparin in acute coronary syndromes N Engl J Med 354 2006 1464 1476
- (2006) N Engl J Med , vol.354 , pp. 1464-1476
- Yusuf, S.¹ Mehta, S.R.² Chrolavicius, S.³ Afzal, R.⁴ Pogue, J.⁵ Granger, C.B.⁶ Budaj, A.⁷ Peters, R.J.G.⁸ Bassand, J.-P.⁹ Wallentin, L.¹⁰ Joyner, C.¹¹ Fox, K.A.A.¹²

11
- 80051533777
- Bleeding in acute coronary syndromes and percutaneous coronary interventions: Position paper by the Working Group on Thrombosis of the European Society of Cardiology
- P.G. Steg, K. Huber, F. Andreotti, H. Arnesen, D. Atar, L. Badimon, J.P. Bassand, R. De Caterina, J.A. Eikelboom, D. Gulba, M. Hamon, G. Helft, K.A. Fox, S.D. Kristensen, S.V. Rao, F.W. Verheugt, P. Widimsky, U. Zeymer, and J.P. Collet Bleeding in acute coronary syndromes and percutaneous coronary interventions: position paper by the Working Group on Thrombosis of the European Society of Cardiology Eur Heart J 32 2011 1854 1864
- (2011) Eur Heart J , vol.32 , pp. 1854-1864
- Steg, P.G.¹ Huber, K.² Andreotti, F.³ Arnesen, H.⁴ Atar, D.⁵ Badimon, L.⁶ Bassand, J.P.⁷ De Caterina, R.⁸ Eikelboom, J.A.⁹ Gulba, D.¹⁰ Hamon, M.¹¹ Helft, G.¹² Fox, K.A.¹³ Kristensen, S.D.¹⁴ Rao, S.V.¹⁵ Verheugt, F.W.¹⁶ Widimsky, P.¹⁷ Zeymer, U.¹⁸ Collet, J.P.¹⁹

12
- 79959696572
- Heparin plus a glycoprotein IIb/IIIa inhibitor versus bivalirudin monotherapy and paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction (HORIZONS-AMI): Final 3-year results from a multicentre, randomised controlled trial
- G.W. Stone, B. Witzenbichler, G. Guagliumi, J.Z. Peruga, B.R. Brodie, D. Dudek, R. Kornowski, F. Hartmann, B.J. Gersh, S.J. Pocock, G. Dangas, S.C. Wong, M. Fahy, H. Parise, and R. Mehran Heparin plus a glycoprotein IIb/IIIa inhibitor versus bivalirudin monotherapy and paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction (HORIZONS-AMI): final 3-year results from a multicentre, randomised controlled trial Lancet 377 2011 2193 2204
- (2011) Lancet , vol.377 , pp. 2193-2204
- Stone, G.W.¹ Witzenbichler, B.² Guagliumi, G.³ Peruga, J.Z.⁴ Brodie, B.R.⁵ Dudek, D.⁶ Kornowski, R.⁷ Hartmann, F.⁸ Gersh, B.J.⁹ Pocock, S.J.¹⁰ Dangas, G.¹¹ Wong, S.C.¹² Fahy, M.¹³ Parise, H.¹⁴ Mehran, R.¹⁵

13
- 84857214255
- Efficacy and safety of enoxaparin versus unfractionated heparin during percutaneous coronary intervention: Systematic review and meta-analysis
- J. Silvain, F. Beygui, O. Barthélémy, C. Pollack Jr., M. Cohen, U. Zeymer, K. Huber, P. Goldstein, G. Cayla, J.-P. Collet, E. Vicaut, and G. Montalescot Efficacy and safety of enoxaparin versus unfractionated heparin during percutaneous coronary intervention: systematic review and meta-analysis Br Med J 344 2012 e553
- (2012) Br Med J , vol.344 , pp. 553
- Silvain, J.¹ Beygui, F.² Barthélémy, O.³ Pollack, Jr.C.⁴ Cohen, M.⁵ Zeymer, U.⁶ Huber, K.⁷ Goldstein, P.⁸ Cayla, G.⁹ Collet, J.-P.¹⁰ Vicaut, E.¹¹ Montalescot, G.¹²

14
- 85172619255
- http://www.emea.europa.eu/docs/en-GB/document-library/ Scientific-guideline/2009/09/WC500002928.pdf.

15
- 79751519297
- Heparin or enoxaparin anticoagulation for primary percutaneous coronary intervention
- D. Brieger, J.-P. Collet, J. Silvain, A. Landivier, O. Barthélémy, F. Beygui, A. Bellemain-Appaix, A. Mercadier, R. Choussat, N. Vignolles, D. Costagliola, and G. Montalescot Heparin or enoxaparin anticoagulation for primary percutaneous coronary intervention Catheter Cardiovasc Interv 77 2011 182 190
- (2011) Catheter Cardiovasc Interv , vol.77 , pp. 182-190
- Brieger, D.¹ Collet, J.-P.² Silvain, J.³ Landivier, A.⁴ Barthélémy, O.⁵ Beygui, F.⁶ Bellemain-Appaix, A.⁷ Mercadier, A.⁸ Choussat, R.⁹ Vignolles, N.¹⁰ Costagliola, D.¹¹ Montalescot, G.¹²

16
- 63049140130
- Efficacy and safety of enoxaparin in combination with and without GP IIb/IIIa inhibitors in unselected patients with ST segment elevation myocardial infarction treated with primary percutaneous coronary intervention
- U. Zeymer, A. Gitt, R. Zahn, C. Jünger, T. Bauer, T. Heer, O. Koeth, and J. Senges Efficacy and safety of enoxaparin in combination with and without GP IIb/IIIa inhibitors in unselected patients with ST segment elevation myocardial infarction treated with primary percutaneous coronary intervention EuroIntervention 4 2009 524 528
- (2009) EuroIntervention , vol.4 , pp. 524-528
- Zeymer, U.¹ Gitt, A.² Zahn, R.³ Jünger, C.⁴ Bauer, T.⁵ Heer, T.⁶ Koeth, O.⁷ Senges, J.⁸

17
- 77950144610
- Low-molecular-weight heparin versus unfractionated heparin in acute ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention with drug-eluting stents
- other Korea Acute Myocardial infarction Registry Investigators
- Y.-J. Li, S.-W. Rha, K.-Y. Chen, K.L. Poddar, Z. Jin, Y. Minami, L. Wang, Q. Dang, G.-P. Li, S. Ramasamy, J.-Y. Park, C.U. Choi, C.U. Choi, J.-W. Kim, E.J. Kim, C.G. Park, H.S. Seo, D.J. Oh, M.H. Jeong, Y.K. Ahn, T.J. Hong, J.S. Park, Y.J. Kim, S.H. Hur, I.W. Seong, J.K. Chae, M.C. Cho, J.H. Bae, D.H. Choi, Y.S. Jang, I.H. Chae, H.S. Kim, C.J. Kim, J.H. Yoon, T.H. Ahn, S.J. Tahk, W.S. Chung, K.B. Seung, S.J. Park other Korea Acute Myocardial infarction Registry Investigators Low-molecular-weight heparin versus unfractionated heparin in acute ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention with drug-eluting stents Am Heart J 159 2010 684 690.e1
- (2010) Am Heart J , vol.159
- Li, Y.-J.¹ Rha, S.-W.² Chen, K.-Y.³ Poddar, K.L.⁴ Jin, Z.⁵ Minami, Y.⁶ Wang, L.⁷ Dang, Q.⁸ Li, G.-P.⁹ Ramasamy, S.¹⁰ Park, J.-Y.¹¹ Choi, C.U.¹² Choi, C.U.¹³ Kim, J.-W.¹⁴ Kim, E.J.¹⁵ Park, C.G.¹⁶ Seo, H.S.¹⁷ Oh, D.J.¹⁸ Jeong, M.H.¹⁹ Ahn, Y.K.²⁰ more..

18
- 76649119159
- Enoxaparin in primary and facilitated percutaneous coronary intervention A formal prospective nonrandomized substudy of the FINESSE trial
- G. Montalescot, S.G. Ellis, M.A. de Belder, L. Janssens, O. Katz, W. Pluta, P. Ecollan, M. Tendera, A.J. van Boven, P. Widimsky, H.R. Andersen, A. Betriu, P. Armstrong, B.R. Brodie, H.C. Herrmann, F.J. Neumann, M.B. Effron, J. Lu, E.S. Barnathan, and E.J. Topol Enoxaparin in primary and facilitated percutaneous coronary intervention A formal prospective nonrandomized substudy of the FINESSE trial JACC Cardiovasc Interv 3 2010 203 212
- (2010) JACC Cardiovasc Interv , vol.3 , pp. 203-212
- Montalescot, G.¹ Ellis, S.G.² De Belder, M.A.³ Janssens, L.⁴ Katz, O.⁵ Pluta, W.⁶ Ecollan, P.⁷ Tendera, M.⁸ Van Boven, A.J.⁹ Widimsky, P.¹⁰ Andersen, H.R.¹¹ Betriu, A.¹² Armstrong, P.¹³ Brodie, B.R.¹⁴ Herrmann, H.C.¹⁵ Neumann, F.J.¹⁶ Effron, M.B.¹⁷ Lu, J.¹⁸ Barnathan, E.S.¹⁹ Topol, E.J.²⁰ more..

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.